China SXT Pharmaceuticals logo
China SXT Pharmaceuticals SXTC
$ 2.02 0.5%

Annual report 2025
added 04-11-2026

report update icon

China SXT Pharmaceuticals Total Current Liabilities 2011-2026 | SXTC

Annual Total Current Liabilities China SXT Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.01 M 8.9 M 14.5 M 17.1 M 18.6 M 12.3 M 6.32 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.6 M 6.01 M 12 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
BioXcel Therapeutics BioXcel Therapeutics
BTAI
53.9 M $ 1.15 - $ 14 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
35.8 M $ 0.87 0.99 % $ 5.85 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Aligos Therapeutics Aligos Therapeutics
ALGS
21.2 M $ 6.6 -1.2 % $ 65.2 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
158 M $ 23.1 0.94 % $ 1.08 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.01 -1.15 % $ 4.96 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
163 M $ 1.42 1.07 % $ 365 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
11 M - -2.5 % $ 5.88 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
47.6 M $ 4.33 - $ 463 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 24.34 -0.77 % $ 3.1 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.57 -1.87 % $ 418 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.2 M $ 3.26 -5.23 % $ 328 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
36.8 M - - $ 3.45 B usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
19.9 M - -0.88 % $ 598 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
20.8 M $ 33.97 0.15 % $ 440 M usaUSA